LPL Financial
TBIO

LPL Financial’s Translate Bio, Inc. Common Stock TBIO Stock Holding History

LPL Financial’s Portfolio TBIO Stock Details TBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-8,140
Closed -$224K – 4480
2021
Q2 		$224K Buy
+8,140
New +$160K ﹤0.01% 3826

LPL Financial's TBIO Position: Q3 2021 in Review

LPL Financial sold out of Translate Bio, Inc. Common Stock (TBIO) in Q3 2021, closing a stake of 8,140 shares — an estimated $224K sold.

LPL Financial first reported a position in TBIO in Q2 2021 and held it in 1 quarter. The position peaked at $224K in Q2 2021. 0 funds tracked by Wall St. Rank hold TBIO as of Q3 2021.

  • LPL Financial reported no remaining Translate Bio, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • LPL Financial sold 8,140 Translate Bio, Inc. Common Stock shares in Q3 2021, an estimated $224K.
  • LPL Financial first reported a position in Translate Bio, Inc. Common Stock in Q2 2021 and held it in 1 quarter.
  • LPL Financial's Translate Bio, Inc. Common Stock position peaked at $224K in Q2 2021.
  • 0 funds tracked by Wall St. Rank held Translate Bio, Inc. Common Stock as of Q3 2021.

Based on LPL Financial's 13F filing for Q3 2021, filed 15 Nov 2021.